Loading...
Dernières publications
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
-
Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
-
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
Chiffres clés
123
Publications avec texte intégral
Open Access
53 %
Mots clés
Skeletal muscle
Inclusion body myositis
B-lymphocyte
Multidisciplinarity
Data integration
Anti-agalsidase antibodies
Muscle
Outcome measures
IMNM
AAV vector
Acute Kidney Injury/epidemiology/etiology
Auto-antibodies
Biomarker
Adeno-associated virus vector
Sphingosine-1-phosphate
Cancer
Myositis
Animals
Adult
Antisynthétase
Aldosterone
Adeno-associated vector
Interferon
Autoimmunity
Amyotrophic lateral sclerosis
Male
AAV vectors
AAV
Autoimmune diseases
Antiphospholipid syndrome
IBM
Inflammatory myopathy
Anti-drug antibodies
Amyotrophy
AAV humoral immunity
Cytokines
Dermatomyositis
Antisynthetase
Myositis and muscle disease
Anti-interleukin-6
Auto-immunité
Biopsy
Adverse drug reactions
Biomarkers
Fabry disease
Dependovirus/genetics/immunology
DM
Lysosomal storage diseases
Auto‐antibodies
Active
Anti‐mitochondrial antibodies
Anti-synthetase syndrome
Adolescence
Female
Middle Aged
Myopathy
Aldostérone
Anti-Mi2
Anémie hémolytique
Idiopathic inflammatory myopathies
Anticorps anti-agalsidase
Arthritis
Antisynthetase syndrome
COVID-19
Autoantibody
Deep immune profiling
Adjudication
Antibody responses
Abnormal movement
Inflammation
Aged
Adeno-associated virus
Cardio-oncology
Immune checkpoint inhibitors
Humans
Prognosis
Anti-MDA5 autoantibodies
Myocarditis
B cell homeostasis
Anti-IgE IgG
Bioelectrical impedance analysis
AAV antibody
Systems biology
Pharmacology
Immunotherapy
Assisted communication devices
Biomarqueurs
Agalsidase
Anticorps spécifique des myosites
Case reports
Gene therapy
Mass cytometry
Antibodies
Interstitial lung disease
Polymyositis
Acid-alpha-glucosidase
Analyses multidimensionnelles
Machine learning
Inborn errors of metabolism
Autoantibodies